Baker Botts L.L.P. announced a major trial victory for its client, Lexion Medical, LLC, after a 7 day jury trial in the United States District Court for the District of Delaware.
The jury found SurgiQuest, Inc. liable for false advertising. The jury rejected SurgiQuest’s false advertising claims against Lexion.
The case was tried before the Honorable Gregory M. Sleet, United States District Court Judge.
SurgiQuest filed the case in 2014 after an earlier filed case by Lexion had been dismissed for lack of jurisdiction.
In addition to the false advertising findings, the jury also found that Lexion had proven by a preponderance of the evidence that SurgiQuest intentionally or willfully made a false advertising statement.
The jury further found that Lexion had proven by a preponderance of the evidence that SurgiQuest intentionally or recklessly engaged in unfair competition.
The jury awarded $2.2 million in lost profit damages and $10 million in punitive damages.
The Baker Botts team lead by David Wille (Picture) included Partner Paul Reilly and Associate Megan LaDriere.
Law Firms: Baker Botts;
Clients: Lexion Medical, LLC;